Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1953 1
1959 1
1960 1
1963 1
1964 2
1965 1
1968 1
1971 1
1972 1
1973 2
1975 3
1976 1
1978 1
1979 5
1980 5
1981 2
1982 2
1984 5
1986 2
1987 4
1988 3
1989 7
1990 3
1991 8
1992 5
1993 13
1994 11
1995 11
1996 6
1997 4
1998 3
1999 8
2000 8
2001 9
2002 8
2003 12
2004 11
2005 17
2006 18
2007 26
2008 23
2009 27
2010 32
2011 46
2012 38
2013 51
2014 53
2015 66
2016 65
2017 66
2018 80
2019 72
2020 125
2021 124
2022 66
Text availability
Article attribute
Article type
Publication date

Search Results

1,035 results
Results by year
Filters applied: . Clear all
Page 1
The emotional impact of Coronavirus 2019-nCoV (new Coronavirus disease).
Lima CKT, Carvalho PMM, Lima IAAS, Nunes JVAO, Saraiva JS, de Souza RI, da Silva CGL, Neto MLR. Lima CKT, et al. Among authors: nunes jvao. Psychiatry Res. 2020 May;287:112915. doi: 10.1016/j.psychres.2020.112915. Epub 2020 Mar 12. Psychiatry Res. 2020. PMID: 32199182 Free PMC article. Review.
Targeting IRAK4 for Degradation with PROTACs.
Nunes J, McGonagle GA, Eden J, Kiritharan G, Touzet M, Lewell X, Emery J, Eidam H, Harling JD, Anderson NA. Nunes J, et al. ACS Med Chem Lett. 2019 Jun 14;10(7):1081-1085. doi: 10.1021/acsmedchemlett.9b00219. eCollection 2019 Jul 11. ACS Med Chem Lett. 2019. PMID: 31312412 Free PMC article.
Discovery and Characterisation of Highly Cooperative FAK-Degrading PROTACs.
Law RP, Nunes J, Chung CW, Bantscheff M, Buda K, Dai H, Evans JP, Flinders A, Klimaszewska D, Lewis AJ, Muelbaier M, Scott-Stevens P, Stacey P, Tame CJ, Watt GF, Zinn N, Queisser MA, Harling JD, Benowitz AB. Law RP, et al. Among authors: nunes j. Angew Chem Int Ed Engl. 2021 Oct 18;60(43):23327-23334. doi: 10.1002/anie.202109237. Epub 2021 Sep 17. Angew Chem Int Ed Engl. 2021. PMID: 34416073
The ROR1 antibody-drug conjugate huXBR1-402-G5-PNU effectively targets ROR1+ leukemia.
Hu EY, Do P, Goswami S, Nunes J, Chiang CL, Elgamal S, Ventura AM, Cheney C, Zapolnik K, Williams E, Mani R, Frissora F, Mo X, Waldmeier L, Beerli RR, Peng H, Rader C, Long M, Grawunder U, Byrd JC, Muthusamy N. Hu EY, et al. Among authors: nunes j. Blood Adv. 2021 Aug 24;5(16):3152-3162. doi: 10.1182/bloodadvances.2020003276. Blood Adv. 2021. PMID: 34424320 Free PMC article.
High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome.
Chretien AS, Devillier R, Granjeaud S, Cordier C, Demerle C, Salem N, Wlosik J, Orlanducci F, Gorvel L, Fattori S, Hospital MA, Pakradouni J, Gregori E, Paul M, Rochigneux P, Pagliardini T, Morey M, Fauriat C, Dulphy N, Toubert A, Luche H, Malissen M, Blaise D, Nunès JA, Vey N, Olive D. Chretien AS, et al. Among authors: nunes ja. Proc Natl Acad Sci U S A. 2021 Jun 1;118(22):e2020459118. doi: 10.1073/pnas.2020459118. Proc Natl Acad Sci U S A. 2021. PMID: 34050021 Free PMC article.
1,035 results